Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-10 5:57 pm Purchase | 2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% | 13,088 (+0.91%) | Filing History |
| 2022-01-10 5:51 pm Purchase | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% | 1,434,932 (New Position) | Filing History |
| 2021-09-09 12:30 pm Purchase | 2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 1,339,793 9.400% | 1,339,793 (New Position) | Filing History |
| 2021-02-16 4:35 pm Purchase | 2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS | Woodline Partners LP | 814,756 5.400% | 814,756 (New Position) | Filing History |
| 2021-02-16 4:17 pm Sale | 2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,503,121 9.990% | -14,918 (-0.98%) | Filing History |
| 2021-02-16 3:14 pm Purchase | 2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS | 683 Capital Management, LLC | 35,900 1.000% | 35,900 (New Position) | Filing History |
| 2021-02-08 10:29 am Purchase | 2021-02-05 | 13G | NOVUS THERAPEUTICS INC NVUS | FMR LLC | 1,004,111 6.623% | 1,004,111 (New Position) | Filing History |
| 2021-01-05 4:38 pm Unchanged | 2020-12-22 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 0.500% | 0 (Unchanged) | Filing History |
| 2021-01-04 4:06 pm Purchase | 2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS | ADAGE CAPITAL PARTNERS GP L.L.C. | 892,555 5.890% | 892,555 (New Position) | Filing History |
| 2021-01-04 4:01 pm Purchase | 2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS | Cormorant Asset Management, LP | 1,415,500 9.890% | 1,415,500 (New Position) | Filing History |
| 2020-12-30 5:27 pm Purchase | 2020-12-28 | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,518,039 10.000% | 3,520 (+0.23%) | Filing History |
| 2020-12-28 5:13 pm Purchase | 2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,514,519 9.990% | 1,319,193 (+675.38%) | Filing History |